Primary Job Title Chief Medical Officer Primary Organization Neurophth Therapeutics
Location Shanghai, Shanghai, China Regions Asia-Pacific (APAC) Gender Male
LinkedIn View on LinkedIn
Guo Xiaoning joined Saisheng in 2020 and is now responsible for the company's R&D management. Before joining the company, Dr. Guo served as a senior scientist at AstraZeneca Pharmaceutical Co., Ltd. from 2007 to 2011; from 2012 to 2014 as the project leader of Johnson (Shanghai) Medical Devices Co., Ltd.; from 2014 to 2018, as Covance ,
Inc. senior director and head of clinical drug development; and from 2018 to 2020, he has served as deputy general manager and clinical development and regulatory affairs director of Jiaochen Biomedical Technology (Shanghai) Co., Ltd.
